We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFL
3376
PIMCO Income Strategy Fund
PFL
$381M
| $128K | ﹤0.01% |
15,373
| – | – |
|
3377
Savara
SVRA
$1.13B
| $128K | ﹤0.01% |
56,001
-37,888
| -40% | -$103K |
|
|
EHAB
3378
DELISTED
Enhabit
EHAB
| $127K | ﹤0.01% |
13,179
-2,575
| -16% | -$23.8K |
|
3379
Genelux
GNLX
$130M
| $126K | ﹤0.01% |
44,024
+1,843
| +4% | +$4.87K |
|
|
HPP
3380
Hudson Pacific Properties
HPP
$834M
| $126K | ﹤0.01% |
6,585
+1,352
| +26% | +$21.9K |
|
3381
Digital Turbine
APPS
$1.02B
| $126K | ﹤0.01% |
21,289
+5,991
| +39% | +$24.6K |
|
3382
LegalZoom.com
LZ
$1.23B
| $123K | ﹤0.01% |
13,857
+752
| +6% | +$6.3K |
|
3383
NeoGenomics
NEO
$1.81B
| $122K | ﹤0.01% |
16,735
+2,840
| +20% | +$22.9K |
|
|
IAS
3384
DELISTED
Integral Ad Science
IAS
| $122K | ﹤0.01% |
+14,699
| New | +$112K |
|
|
RAPP
3385
Rapport Therapeutics
RAPP
$1.95B
| $121K | ﹤0.01% |
+10,602
| New | +$113K |
|
3386
Absci
ABSI
$1.28B
| $120K | ﹤0.01% |
46,882
+27,775
| +145% | +$78.2K |
|
|
DAWN
3387
DELISTED
Day One Biopharmaceuticals
DAWN
| $120K | ﹤0.01% |
+18,507
| New | +$127K |
|
3388
Taysha Gene Therapies
TSHA
$1.59B
| $120K | ﹤0.01% |
51,981
-26,354
| -34% | -$57.3K |
|
3389
Regenxbio
RGNX
$623M
| $120K | ﹤0.01% |
14,620
-1,514
| -9% | -$12.7K |
|
|
CMRC
3390
Commerce.com Inc Series 1
CMRC
$224M
| $118K | ﹤0.01% |
23,659
-1,538
| -6% | -$7.92K |
|
3391
Helix Energy Solutions
HLX
$1.46B
| $117K | ﹤0.01% |
18,713
-39,799
| -68% | -$264K |
|
3392
Gran Tierra Energy
GTE
$260M
| $117K | ﹤0.01% |
+24,477
| New | +$116K |
|
3393
Lionsgate Studios
LION
$3.88B
| $117K | ﹤0.01% |
+20,068
| New | +$134K |
|
3394
Fulcrum Therapeutics
FULC
$248M
| $117K | ﹤0.01% |
+16,939
| New | +$90.6K |
|
|
CHI
3395
Calamos Convertible Opportunities and Income Fund
CHI
$1.02B
| $116K | ﹤0.01% |
+11,000
| New | +$110K |
|
3396
FreightCar America
RAIL
$275M
| $115K | ﹤0.01% |
13,300
| – | – |
|
3397
Hillman Solutions
HLMN
$1.56B
| $113K | ﹤0.01% |
15,788
-5,965
| -27% | -$44.7K |
|
3398
Oric Pharmaceuticals
ORIC
$1.25B
| $113K | ﹤0.01% |
+11,095
| New | +$74.5K |
|
3399
Blend Labs
BLND
$409M
| $112K | ﹤0.01% |
34,036
+15,276
| +81% | +$51.8K |
|
3400
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$900M
| $112K | ﹤0.01% |
+11,281
| New | +$112K |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.